[
  {
    "ts": null,
    "headline": "Thankful Investors - Last 20 Years",
    "summary": "AI chipmaker Nvidia has easily been the best-performing stock over the last twenty years, and it has made a large number of investors extremely wealthy.",
    "url": "https://finnhub.io/api/news?id=16f7e87d74b034d67dd31a0d74a138ab87f630ed765a15227c79df8ead1c1fe9",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732652700,
      "headline": "Thankful Investors - Last 20 Years",
      "id": 131654683,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/175599141/image_175599141.jpg?io=getty-c-w1536",
      "related": "REGN",
      "source": "SeekingAlpha",
      "summary": "AI chipmaker Nvidia has easily been the best-performing stock over the last twenty years, and it has made a large number of investors extremely wealthy.",
      "url": "https://finnhub.io/api/news?id=16f7e87d74b034d67dd31a0d74a138ab87f630ed765a15227c79df8ead1c1fe9"
    }
  },
  {
    "ts": null,
    "headline": "Invesco Health Care Fund Q3 2024 Commentary",
    "summary": "Invesco Health Care Fund underperformed its benchmark. Despite earlier signs of improving trends, our health care outlook is bearish. Read more here.",
    "url": "https://finnhub.io/api/news?id=8811a159dd6bae05dcf408a9f48cd5d03a26ef619260c992cad970093f4bc185",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732624620,
      "headline": "Invesco Health Care Fund Q3 2024 Commentary",
      "id": 131646502,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/183355336/image_183355336.jpg?io=getty-c-w1536",
      "related": "REGN",
      "source": "SeekingAlpha",
      "summary": "Invesco Health Care Fund underperformed its benchmark. Despite earlier signs of improving trends, our health care outlook is bearish. Read more here.",
      "url": "https://finnhub.io/api/news?id=8811a159dd6bae05dcf408a9f48cd5d03a26ef619260c992cad970093f4bc185"
    }
  },
  {
    "ts": null,
    "headline": "Law Offices of Howard G. Smith Continues Investigation of Regeneron Pharmaceuticals, Inc. (REGN) on Behalf of Investors",
    "summary": "Law Offices of Howard G. Smith continues its investigation on behalf of Regeneron Pharmaceuticals, Inc. investors concerning the Company’s possible violations of federal securities laws.On...",
    "url": "https://finnhub.io/api/news?id=d4cd4b178b3ad122be8023e2dc2d53be1cba9182c519e2c60f2a2183bcf57864",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732622463,
      "headline": "Law Offices of Howard G. Smith Continues Investigation of Regeneron Pharmaceuticals, Inc. (REGN) on Behalf of Investors",
      "id": 131643752,
      "image": "",
      "related": "REGN",
      "source": "Finnhub",
      "summary": "Law Offices of Howard G. Smith continues its investigation on behalf of Regeneron Pharmaceuticals, Inc. investors concerning the Company’s possible violations of federal securities laws.On...",
      "url": "https://finnhub.io/api/news?id=d4cd4b178b3ad122be8023e2dc2d53be1cba9182c519e2c60f2a2183bcf57864"
    }
  }
]